LIPIDS: 60 Second Insights

Published: 10 August 2018

  • Views:

    Views Icon 329
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 329
  • Likes:

    Heart Icon 0

Overview

A short series of 60-second insight videos on the LIPIDS trial.

Series overview

Part 1

Which emerging compounds show the most promise in reducing LDL?

Part 2

What is required for PCSK9s to get wider spread adoption?

Part 3

How important is inflammation in atherosclerosis?

Part 4

Are statins over (or under) prescribed?

Part 5

Is cholesterol being managed sub- optimally? If so, what needs to improve?

Part 6

How low should LDL go?

Part 7

Is HDL good cholesterol?

Part 8

What is the greatest unmet need in lipid management?

Faculty Biographies

Christopher P Cannon

Christopher P Cannon

Professor

Dr. Cannon is a Professor of Medicine at Harvard Medical School, and senior physician in the Preventive Cardiology section of the Cardiovascular Division at Brigham and Women’s Hospital. He currently serves as Education Director in the Cardiovascular Innovation group. He worked for 25 years as an investigator in the TIMI Study Group, then with the Harvard Clinical Research Institute (now Baim Institute).  

He earned his MD from Columbia University College of Physicians and Surgeons in New York and did internal medicine residency at Columbia Presbyterian Medical Center, and cardiovascular fellowship at Brigham and Women’s Hospital.

Dr. Cannon has published over 1000 original articles, reviews or book chapters in the field of acute coronary syndromes and prevention and has authored or edited 18 books. He has received numerous awards, including leadership awards from the American College of Cardiology, American Heart Association and National Lipid Association…

View full profile